Deferoxamine: Clinical Trials

6 trials of Deferoxamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 4, Terminated 1, Unknown 1

Follow Deferoxamine: new trials by email Literature Review of Deferoxamine trials Research Report on Deferoxamine

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection
Desferal 500 MG Injection - Covid 19
Phase 4UnknownHesham Al-Inany2002020-06-012020-05-15
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Deferiprone, Deferoxamine - Iron Overload, Sickle Cell Disease
Phase 4TerminatedApoPharma2302014-04-172021-08-10
Pilot Study for Patients With Poor Response to Deferasirox
Deferoxamine, Deferasirox, HIDA - Transfusion-dependent Hemachromatosis, Thalassemia Major
Phase 4CompletedBoston Children's Hospital152008-03-012024-02-12
Efficacy Study in Removing Excess Iron From the Heart
Ferriprox (deferiprone), Desferal (deferoxamine) - Thalassemia Major, Hemosiderosis
Phase 4CompletedApoPharma602002-12-012016-01-05
Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
Deferoxamine and Deferiprone, Deferoxamine - Iron Overload, Cardiomyopathy
Phase 4CompletedOspedale Microcitemico2001-12-012008-12-02
Efficacy Study of the Use of Sequential DFP-DFO Versus DFP
Deferiprone (DFP) and Deferoxamine (DFO), Deferiprone (DFP) - Beta-Thalassemia, Thalassemia Major
Phase 4CompletedAzienda Ospedaliera V. Cervello2132000-09-012008-08-13

Conditions studied

Iron Overload (3)  ·  beta-Thalassemia (3)  ·  Anemia, Sickle Cell (2)  ·  Thalassemia (2)  ·  COVID-19 (1)  ·  Cardiomyopathies (1)  ·  Hemochromatosis (1)  ·  Hemosiderosis (1)

Sponsors

ApoPharma (2)  ·  Azienda Ospedaliera V. Cervello (1)  ·  Boston Children's Hospital (1)  ·  Hesham Al-Inany (1)  ·  Ospedale Microcitemico (1)

Countries

Italy (3)  ·  United States (2)  ·  Brazil (1)  ·  Canada (1)  ·  Egypt (1)  ·  Greece (1)  ·  Saudi Arabia (1)  ·  Tunisia (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Antonio Piga, M.D. (1)  ·  Deborah Chirnomas, MD (1)  ·  Janet Kwiatkowski, MD (1)  ·  Maria E Lai, MD (1)  ·  Markissia Karagiorga, M.D. (1)  ·  Renzo Galanello, M.D. (1)  ·  Vassilis Ladis, M.D. (1)

Results publications

PMID 37975597, PMID 19236376, PMID 19724055, PMID 34847228, PMID 37807937